The global Peanut Allergy Therapeutics market size was valued at USD 698 million in 2022 and is forecast to a readjusted size of USD 5942.9 million by 2029 with a CAGR of 35.8% during review period.
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%. Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo, top 5 players took 52% market share.
This report is a detailed and comprehensive analysis for global Peanut Allergy Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Peanut Allergy Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Peanut Allergy Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Peanut Allergy Therapeutics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2018-2029
Global Peanut Allergy Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peanut Allergy Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peanut Allergy Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Hospital Pharmacy
Retail Pharmacy
Other
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths
- Growing awareness and prevalence of peanut allergies is driving demand for innovative therapeutics.
- Advancements in immunotherapy and biologics offer promising treatment options, potentially improving patient outcomes.
Weaknesses
- High cost of new therapies may limit accessibility for patients and healthcare providers.
- Limited understanding of long-term efficacy and safety of peanut allergy treatments may hinder market growth.
Opportunities
- Increasing investment in research and development can lead to the discovery of novel treatment methods.
- Expansion of the market in emerging economies presents opportunities for growth and diversification.
Threats
- Regulatory challenges and lengthy approval processes may delay product launches.
- Competition from alternative therapies and rising awareness of dietary management can impact market share.
Political
- Government policies and funding for allergy research and immunotherapy can encourage innovation and market growth.
- Regulatory approval processes for new therapies can impact market entry and competition.
Economic
- Rising healthcare costs may limit patient access to advanced peanut allergy treatments, affecting market expansion.
- Economic growth in emerging markets offers opportunities for new therapeutic products at more affordable prices.
Social
- Increased awareness and diagnosis of peanut allergies are leading to higher demand for treatment solutions.
- Patient advocacy and support groups are becoming more influential, driving the need for better treatments.
Technological
- Advancements in immunotherapy and biotechnology are enabling the development of more effective peanut allergy treatments.
- Digital health tools, such as apps and wearables, are enhancing treatment adherence and patient monitoring.
Environmental
- Sustainability concerns regarding the production of therapeutic products may influence market dynamics.
- Environmental factors may affect the availability and safety of ingredients used in peanut allergy treatments.
Legal
- Stringent regulations regarding drug approval and safety standards can impact the speed at which new therapies are introduced.
- Intellectual property laws may affect competition, with patenting of novel treatments providing a market advantage.
Suppliers
- Pharmaceutical companies and biotechnology firms that develop and manufacture peanut allergy therapeutics.
- Raw material suppliers providing active ingredients and excipients necessary for therapeutic formulations.
Inputs
- Research and development efforts to create effective peanut allergy treatments, including clinical trials and studies.
- Regulatory approvals and guidelines required for marketing and distributing therapeutics in different regions.
Processes
- Development of innovative therapies, such as immunotherapy and biologics, targeting peanut allergies.
- Conducting clinical trials to assess safety and efficacy, followed by regulatory submissions for product approval.
Outputs
- Approved peanut allergy therapeutics ready for market, including oral immunotherapy and biologic agents.
- Educational materials and support resources for patients and healthcare providers regarding treatment options.
Customers
- Patients diagnosed with peanut allergies seeking effective treatment solutions.
- Healthcare providers, including allergists and primary care physicians, prescribing therapies to manage peanut allergies.
Threat of New Entrants
- High barriers to entry due to the significant investment required for research, development, and regulatory approvals.
- However, advancements in biotechnology may lower these barriers, allowing smaller firms to enter the market with innovative therapies.
Bargaining Power of Suppliers
- Limited number of suppliers for specialized ingredients and biologics may increase their bargaining power.
- However, growing competition in the supply chain may mitigate supplier power as more alternatives become available.
Bargaining Power of Buyers
- Patients and healthcare providers have limited bargaining power due to the niche nature of peanut allergy therapeutics.
- Rising demand for effective treatments may give buyers more influence over pricing and treatment options.
Threat of Substitutes
- Dietary management and avoidance strategies serve as substitutes, limiting the overall demand for pharmaceutical treatments.
- However, the emergence of new therapies and increasing treatment options reduce the threat of substitutes in the long run.
Industry Rivalry
- The market for peanut allergy therapeutics is competitive with several pharmaceutical companies developing and marketing treatments.
- High competition from both established players and new entrants can lead to pressure on pricing and innovation.
Raw Materials and Components
- Active ingredients, such as peanut proteins and biologic agents, are sourced from specialized suppliers with expertise in allergy treatments.
- High-quality excipients and delivery systems, such as oral tablets or injectables, are critical for ensuring the efficacy and safety of treatments.
Research and Development
- Investment in R&D is essential for developing new and more effective peanut allergy treatments, including immunotherapies and biologic drugs.
- Collaboration with academic institutions and biotech companies is crucial for advancing scientific understanding and treatment innovations in the field.
Manufacturing and Production
- Large-scale production facilities are required for the manufacturing of peanut allergy therapeutics, including biologics and immunotherapy treatments.
- Stringent quality control and regulatory compliance during production ensure safety and effectiveness in the final product.
Distribution and Supply Chain
- Distribution networks need to be robust to ensure timely delivery of therapeutics to healthcare providers and pharmacies worldwide.
- Partnerships with logistics companies and healthcare distributors are vital for ensuring access to both emerging and established markets.
Healthcare Providers
- Healthcare providers, including allergists and primary care physicians, are key players in prescribing peanut allergy treatments to patients.
- Training and education for healthcare professionals are essential to ensure they are equipped to manage and advise on new therapeutic options.
Patients and End Users
- Patients, particularly those with severe peanut allergies, are the end consumers of therapeutics, seeking effective and accessible treatments.
- Patient advocacy groups and support networks play a crucial role in raising awareness and driving demand for new and innovative treatments.
Chapter 1, to describe Peanut Allergy Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peanut Allergy Therapeutics, with revenue, gross margin and global market share of Peanut Allergy Therapeutics from 2018 to 2023.
Chapter 3, the Peanut Allergy Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Peanut Allergy Therapeutics market forecast, by regions, type and distribution channel, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Peanut Allergy Therapeutics.
Chapter 13, to describe Peanut Allergy Therapeutics research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Peanut Allergy Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Peanut Allergy Therapeutics by Type
1.3.1 Overview: Global Peanut Allergy Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Peanut Allergy Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Epinephrine Injection
1.3.4 Antihistamines
1.3.5 Oral Immunotherapy
1.3.6 Other
1.4 Global Peanut Allergy Therapeutics Market by Distribution Channel
1.4.1 Overview: Global Peanut Allergy Therapeutics Market Size by Distribution Channel: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Peanut Allergy Therapeutics Market Size & Forecast
1.6 Global Peanut Allergy Therapeutics Market Size and Forecast by Region
1.6.1 Global Peanut Allergy Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Peanut Allergy Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Peanut Allergy Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Peanut Allergy Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Peanut Allergy Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Peanut Allergy Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Peanut Allergy Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Mylan
2.1.1 Mylan Details
2.1.2 Mylan Major Business
2.1.3 Mylan Peanut Allergy Therapeutics Product and Solutions
2.1.4 Mylan Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Mylan Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Peanut Allergy Therapeutics Product and Solutions
2.2.4 Bayer Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments and Future Plans
2.3 UCB Pharma
2.3.1 UCB Pharma Details
2.3.2 UCB Pharma Major Business
2.3.3 UCB Pharma Peanut Allergy Therapeutics Product and Solutions
2.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 UCB Pharma Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J Peanut Allergy Therapeutics Product and Solutions
2.4.4 J & J Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 J & J Recent Developments and Future Plans
2.5 Perrigo
2.5.1 Perrigo Details
2.5.2 Perrigo Major Business
2.5.3 Perrigo Peanut Allergy Therapeutics Product and Solutions
2.5.4 Perrigo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Perrigo Recent Developments and Future Plans
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Peanut Allergy Therapeutics Product and Solutions
2.6.4 GSK Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GSK Recent Developments and Future Plans
2.7 Kaleo
2.7.1 Kaleo Details
2.7.2 Kaleo Major Business
2.7.3 Kaleo Peanut Allergy Therapeutics Product and Solutions
2.7.4 Kaleo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Kaleo Recent Developments and Future Plans
2.8 Amneal Pharma
2.8.1 Amneal Pharma Details
2.8.2 Amneal Pharma Major Business
2.8.3 Amneal Pharma Peanut Allergy Therapeutics Product and Solutions
2.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Amneal Pharma Recent Developments and Future Plans
2.9 ALK Abello
2.9.1 ALK Abello Details
2.9.2 ALK Abello Major Business
2.9.3 ALK Abello Peanut Allergy Therapeutics Product and Solutions
2.9.4 ALK Abello Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ALK Abello Recent Developments and Future Plans
2.10 Aimmune Therapeutics
2.10.1 Aimmune Therapeutics Details
2.10.2 Aimmune Therapeutics Major Business
2.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aimmune Therapeutics Recent Developments and Future Plans
2.11 HUAPONT Pharm
2.11.1 HUAPONT Pharm Details
2.11.2 HUAPONT Pharm Major Business
2.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Product and Solutions
2.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 HUAPONT Pharm Recent Developments and Future Plans
2.12 Allergy Therapeutics
2.12.1 Allergy Therapeutics Details
2.12.2 Allergy Therapeutics Major Business
2.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Allergy Therapeutics Recent Developments and Future Plans
2.13 ASIT Biotech
2.13.1 ASIT Biotech Details
2.13.2 ASIT Biotech Major Business
2.13.3 ASIT Biotech Peanut Allergy Therapeutics Product and Solutions
2.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ASIT Biotech Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Peanut Allergy Therapeutics Product and Solutions
2.14.4 Sanofi Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments and Future Plans
2.15 DBV Technologies
2.15.1 DBV Technologies Details
2.15.2 DBV Technologies Major Business
2.15.3 DBV Technologies Peanut Allergy Therapeutics Product and Solutions
2.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 DBV Technologies Recent Developments and Future Plans
2.16 HAL Allergy
2.16.1 HAL Allergy Details
2.16.2 HAL Allergy Major Business
2.16.3 HAL Allergy Peanut Allergy Therapeutics Product and Solutions
2.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 HAL Allergy Recent Developments and Future Plans
2.17 Intrommune Therapeutics
2.17.1 Intrommune Therapeutics Details
2.17.2 Intrommune Therapeutics Major Business
2.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Intrommune Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Peanut Allergy Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Peanut Allergy Therapeutics by Company Revenue
3.2.2 Top 3 Peanut Allergy Therapeutics Players Market Share in 2022
3.2.3 Top 6 Peanut Allergy Therapeutics Players Market Share in 2022
3.3 Peanut Allergy Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Peanut Allergy Therapeutics Market: Region Footprint
3.3.2 Peanut Allergy Therapeutics Market: Company Product Type Footprint
3.3.3 Peanut Allergy Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Peanut Allergy Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Peanut Allergy Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Distribution Channel
5.1 Global Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2023)
5.2 Global Peanut Allergy Therapeutics Market Forecast by Distribution Channel (2024-2029)
6 North America
6.1 North America Peanut Allergy Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2029)
6.3 North America Peanut Allergy Therapeutics Market Size by Country
6.3.1 North America Peanut Allergy Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Peanut Allergy Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2029)
7.3 Europe Peanut Allergy Therapeutics Market Size by Country
7.3.1 Europe Peanut Allergy Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2029)
8.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region
8.3.1 Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Peanut Allergy Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2029)
9.3 South America Peanut Allergy Therapeutics Market Size by Country
9.3.1 South America Peanut Allergy Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2029)
10.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country
10.3.1 Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Peanut Allergy Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Peanut Allergy Therapeutics Market Drivers
11.2 Peanut Allergy Therapeutics Market Restraints
11.3 Peanut Allergy Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Peanut Allergy Therapeutics Industry Chain
12.2 Peanut Allergy Therapeutics Upstream Analysis
12.3 Peanut Allergy Therapeutics Midstream Analysis
12.4 Peanut Allergy Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Peanut Allergy Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Peanut Allergy Therapeutics Consumption Value by Distribution Channel, (USD Million), 2018 & 2022 & 2029
Table 3. Global Peanut Allergy Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Peanut Allergy Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Mylan Company Information, Head Office, and Major Competitors
Table 6. Mylan Major Business
Table 7. Mylan Peanut Allergy Therapeutics Product and Solutions
Table 8. Mylan Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Mylan Recent Developments and Future Plans
Table 10. Bayer Company Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Peanut Allergy Therapeutics Product and Solutions
Table 13. Bayer Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bayer Recent Developments and Future Plans
Table 15. UCB Pharma Company Information, Head Office, and Major Competitors
Table 16. UCB Pharma Major Business
Table 17. UCB Pharma Peanut Allergy Therapeutics Product and Solutions
Table 18. UCB Pharma Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. UCB Pharma Recent Developments and Future Plans
Table 20. J & J Company Information, Head Office, and Major Competitors
Table 21. J & J Major Business
Table 22. J & J Peanut Allergy Therapeutics Product and Solutions
Table 23. J & J Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. J & J Recent Developments and Future Plans
Table 25. Perrigo Company Information, Head Office, and Major Competitors
Table 26. Perrigo Major Business
Table 27. Perrigo Peanut Allergy Therapeutics Product and Solutions
Table 28. Perrigo Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Perrigo Recent Developments and Future Plans
Table 30. GSK Company Information, Head Office, and Major Competitors
Table 31. GSK Major Business
Table 32. GSK Peanut Allergy Therapeutics Product and Solutions
Table 33. GSK Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GSK Recent Developments and Future Plans
Table 35. Kaleo Company Information, Head Office, and Major Competitors
Table 36. Kaleo Major Business
Table 37. Kaleo Peanut Allergy Therapeutics Product and Solutions
Table 38. Kaleo Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Kaleo Recent Developments and Future Plans
Table 40. Amneal Pharma Company Information, Head Office, and Major Competitors
Table 41. Amneal Pharma Major Business
Table 42. Amneal Pharma Peanut Allergy Therapeutics Product and Solutions
Table 43. Amneal Pharma Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Amneal Pharma Recent Developments and Future Plans
Table 45. ALK Abello Company Information, Head Office, and Major Competitors
Table 46. ALK Abello Major Business
Table 47. ALK Abello Peanut Allergy Therapeutics Product and Solutions
Table 48. ALK Abello Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. ALK Abello Recent Developments and Future Plans
Table 50. Aimmune Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Aimmune Therapeutics Major Business
Table 52. Aimmune Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 53. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aimmune Therapeutics Recent Developments and Future Plans
Table 55. HUAPONT Pharm Company Information, Head Office, and Major Competitors
Table 56. HUAPONT Pharm Major Business
Table 57. HUAPONT Pharm Peanut Allergy Therapeutics Product and Solutions
Table 58. HUAPONT Pharm Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. HUAPONT Pharm Recent Developments and Future Plans
Table 60. Allergy Therapeutics Company Information, Head Office, and Major Competitors
Table 61. Allergy Therapeutics Major Business
Table 62. Allergy Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 63. Allergy Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Allergy Therapeutics Recent Developments and Future Plans
Table 65. ASIT Biotech Company Information, Head Office, and Major Competitors
Table 66. ASIT Biotech Major Business
Table 67. ASIT Biotech Peanut Allergy Therapeutics Product and Solutions
Table 68. ASIT Biotech Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ASIT Biotech Recent Developments and Future Plans
Table 70. Sanofi Company Information, Head Office, and Major Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Peanut Allergy Therapeutics Product and Solutions
Table 73. Sanofi Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Sanofi Recent Developments and Future Plans
Table 75. DBV Technologies Company Information, Head Office, and Major Competitors
Table 76. DBV Technologies Major Business
Table 77. DBV Technologies Peanut Allergy Therapeutics Product and Solutions
Table 78. DBV Technologies Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. DBV Technologies Recent Developments and Future Plans
Table 80. HAL Allergy Company Information, Head Office, and Major Competitors
Table 81. HAL Allergy Major Business
Table 82. HAL Allergy Peanut Allergy Therapeutics Product and Solutions
Table 83. HAL Allergy Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. HAL Allergy Recent Developments and Future Plans
Table 85. Intrommune Therapeutics Company Information, Head Office, and Major Competitors
Table 86. Intrommune Therapeutics Major Business
Table 87. Intrommune Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 88. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Intrommune Therapeutics Recent Developments and Future Plans
Table 90. Global Peanut Allergy Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 91. Global Peanut Allergy Therapeutics Revenue Share by Players (2018-2023)
Table 92. Breakdown of Peanut Allergy Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Peanut Allergy Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Peanut Allergy Therapeutics Players
Table 95. Peanut Allergy Therapeutics Market: Company Product Type Footprint
Table 96. Peanut Allergy Therapeutics Market: Company Product Application Footprint
Table 97. Peanut Allergy Therapeutics New Market Entrants and Barriers to Market Entry
Table 98. Peanut Allergy Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Peanut Allergy Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Peanut Allergy Therapeutics Consumption Value Share by Type (2018-2023)
Table 101. Global Peanut Allergy Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 102. Global Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023)
Table 103. Global Peanut Allergy Therapeutics Consumption Value Forecast by Distribution Channel (2024-2029)
Table 104. North America Peanut Allergy Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Peanut Allergy Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 107. North America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 108. North America Peanut Allergy Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Peanut Allergy Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Peanut Allergy Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Peanut Allergy Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 113. Europe Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 114. Europe Peanut Allergy Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Peanut Allergy Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 119. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 120. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Peanut Allergy Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Peanut Allergy Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Peanut Allergy Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 125. South America Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 126. South America Peanut Allergy Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Peanut Allergy Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
Table 131. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
Table 132. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Peanut Allergy Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Peanut Allergy Therapeutics Raw Material
Table 135. Key Suppliers of Peanut Allergy Therapeutics Raw Materials
List of Figures
Figure 1. Peanut Allergy Therapeutics Picture
Figure 2. Global Peanut Allergy Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Peanut Allergy Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Epinephrine Injection
Figure 5. Antihistamines
Figure 6. Oral Immunotherapy
Figure 7. Other
Figure 8. Global Peanut Allergy Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel in 2022
Figure 10. Hospital Pharmacy Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Peanut Allergy Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Peanut Allergy Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Peanut Allergy Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Peanut Allergy Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Peanut Allergy Therapeutics Consumption Value Market Share by Region in 2022
Figure 18. North America Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Peanut Allergy Therapeutics Revenue Share by Players in 2022
Figure 24. Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Peanut Allergy Therapeutics Market Share in 2022
Figure 26. Global Top 6 Players Peanut Allergy Therapeutics Market Share in 2022
Figure 27. Global Peanut Allergy Therapeutics Consumption Value Share by Type (2018-2023)
Figure 28. Global Peanut Allergy Therapeutics Market Share Forecast by Type (2024-2029)
Figure 29. Global Peanut Allergy Therapeutics Consumption Value Share by Distribution Channel (2018-2023)
Figure 30. Global Peanut Allergy Therapeutics Market Share Forecast by Distribution Channel (2024-2029)
Figure 31. North America Peanut Allergy Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 33. North America Peanut Allergy Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Peanut Allergy Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 39. Europe Peanut Allergy Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 41. France Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Peanut Allergy Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 47. Asia-Pacific Peanut Allergy Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 48. China Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. India Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Peanut Allergy Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 56. South America Peanut Allergy Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Peanut Allergy Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Peanut Allergy Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
Figure 61. Middle East and Africa Peanut Allergy Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Peanut Allergy Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 65. Peanut Allergy Therapeutics Market Drivers
Figure 66. Peanut Allergy Therapeutics Market Restraints
Figure 67. Peanut Allergy Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Peanut Allergy Therapeutics in 2022
Figure 70. Manufacturing Process Analysis of Peanut Allergy Therapeutics
Figure 71. Peanut Allergy Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
